Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  denosumab
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-12 of 12 for your search:
Start Over
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20080560, NCT00925600
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20090482, NCT01345019
A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 114273, NCT01920568
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 96/12, 000000685, 2014-001189-87, NCT02051218
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ETOP 5-12 / EORTC 08111, 2013-003156-21, 20080166, NCT02129699
Study of AMG 162 in Subjects with Advanced Cancer Currently Being Treated with Intravenous (IV) Bisphosphonates
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040114, UCLA-0501073-01, AMGEN-20040114, NCT00104650
Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCSF Protocol No. 117527, NCT01545648
A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IJB-BCTL- 20119167, 2011-006224-21, NCT01864798
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20120249, NCT01951586
Phase II Trial of Ra-223 Dichloride and Hormonal Treatment
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2014-0508, NCI-2015-00508, NCT02366130
Anakinra or Denosumab and Everolimus in Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-1043, NCI-2012-01156, NCT01624766
Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
Phase: No phase specified
Type: Health services research
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20110102, NCT01998607
Start Over